scispace - formally typeset
P

Palli Valapila Abdulrouf

Researcher at Hamad Medical Corporation

Publications -  18
Citations -  57

Palli Valapila Abdulrouf is an academic researcher from Hamad Medical Corporation. The author has contributed to research in topics: Medicine & Pharmacy. The author has an hindex of 3, co-authored 12 publications receiving 28 citations.

Papers
More filters
Journal ArticleDOI

A retrospective drug use evaluation of cabergoline for lactation inhibition at a tertiary care teaching hospital in Qatar.

TL;DR: Cabergoline was mainly used to inhibit lactation for patients with stillbirth, abortion, and neonatal death, and in mothers who use medications for other medical conditions, benefits and risks of breastfeeding should be carefully balanced before prescribing cabergoline.
Journal ArticleDOI

Evidence of community pharmacists' response preparedness during COVID-19 public health crisis: A cross-sectional study.

TL;DR: In this article, the authors investigated the current practices, response preparedness and professional development needs of community pharmacists in Qatar and found that 77% of pharmacists either agreed or agreed that they have all the necessary COVID-19 related emergency response preparation and training.
Journal ArticleDOI

Incidence, Risk Factors, and Outcomes of Preterm and Early Term Births: A Population-Based Register Study

TL;DR: In this article, the authors examined 15,865 singleton live births using 12-month retrospective registry data from the PEARL-Peristat Study and found that all groups of PTB and ETB were significantly associated with low birth weight (LBW), large for gestational age (LGA) births, caesarean delivery, and neonatal intensive care unit (NICU)/or death of neonate in labor room (LR)/operation theatre (OT).
Journal ArticleDOI

Misoprostol for miscarriage management in a woman with previous five cesarean deliveries: a case report and literature review

TL;DR: It is concluded that adopting a low-dose misoprostol protocol could be potentially safe and effective in managing second trimester missed miscarriage in women with repeated cesarean deliveries and/or uterine rupture history.